Literature DB >> 11377179

Enantioselective synthesis and absolute configuration of (-)-1-(benzofuran-2-yl)-2-propylaminopentane, ((-)-BPAP), a highly potent and selective catecholaminergic activity enhancer.

T Oka1, T Yasusa, T Ando, M Watanabe, F Yoneda, T Ishida, J Knoll.   

Abstract

Enantioselective synthesis and absolute configuration of (-)-1-(benzofuran-2-yl)-2-propylaminopentane ((-)-BPAP), which is a highly potent and selective catecholaminergic activity enhancer (CAE) substance, are described. The synthetic approach consists of the coupling reaction of benzofuran with (R)-N-tosyl-2-propylazirizine or (R)-N-methoxy-N-methylnorvaliamide, followed by appropriate modifications of the resulting coupling products. As the results, (-)-BPAP turned out to have the R configuration, which was finally confirmed by X-ray crystallographic analysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377179     DOI: 10.1016/s0968-0896(00)00341-2

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

Review 1.  Enhancer regulation/endogenous and synthetic enhancer compounds: a neurochemical concept of the innate and acquired drives.

Authors:  Joseph Knoll
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

2.  Enhancer Regulation of Dopaminergic Neurochemical Transmission in the Striatum.

Authors:  Laszlo G Harsing; Joseph Knoll; Ildiko Miklya
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

3.  The fate of (-)1-(benzofuran-2-yl)-2-propylaminopentane . HCl, (-)-BPAP, in rats, a potent enhancer of the impulse-evoked release of catecholamines and serotonin in the brain.

Authors:  Kálmán Magyar; Joseph Lengyel; Andrea Bolehovszky; Bertha Knoll; Iidikó Miklya; Joseph Knoll
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jul-Sep       Impact factor: 2.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.